Engineered inhaled nanocatalytic therapy for ischemic cerebrovascular disease by inducing autophagy of abnormal mitochondria

Mitochondrial dysfunction and subsequent accumulation of reactive oxygen species (ROS) are key contributors to the pathology of ischemic cerebrovascular disease. Therefore, elimination of ROS and damaged mitochondria is crucial for the effective treatment of this disease. For this purpose, we design...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Deping, Li, Bowen, Wang, Shuchao, Hao, Yingjian, Wang, Hua, Sun, Wei, Cao, Jimin, Zhou, Xin, Zheng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421937/
https://www.ncbi.nlm.nih.gov/pubmed/37567914
http://dx.doi.org/10.1038/s41536-023-00315-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421937/
https://www.ncbi.nlm.nih.gov/pubmed/37567914
http://dx.doi.org/10.1038/s41536-023-00315-1

Ejemplares similares